Post-perturbational transcriptional signatures of cancer cell line vulnerabilities
Author:
Jones Andrew,Tsherniak Aviad,McFarland James M.
Abstract
AbstractWhile chemical and genetic viability screens in cancer cell lines have identified many promising cancer vulnerabilities, simple univariate readouts of cell proliferation fail to capture the complex cellular responses to perturbations. Complementarily, gene expression profiling offers an information-rich measure of cell state that can provide a more detailed account of cellular responses to perturbations. Relatively little is known, however, about the relationship between transcriptional responses to per-turbations and the long-term cell viability effects of those perturbations. To address this question, we integrated thousands of post-perturbational transcriptional profiles from the Connectivity Map with large-scale screens of cancer cell lines’ viability response to genetic and chemical perturbations. This analysis revealed a generalized transcriptional signature associated with reduced viability across perturbations, which was consistent across post-perturbation time-points, perturbation types, and viability datasets. At a more granular level, we lay out the landscape of treatment-specific expression-viability relationships across a broad panel of drugs and genetic reagents, and we demonstrate that these post-perturbational expression signatures can be used to infer long-term viability. Together, these results help unmask the transcriptional changes that are associated with perturbation-induced viability loss in cancer cell lines.
Publisher
Cold Spring Harbor Laboratory
Reference28 articles.
1. An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules 2. The Drug Repurposing Hub: a next-generation drug library and information resource 3. Corsello, S.M. , Nagari, R.T. , Spangler, R.D. , Rossen, J. , Kocak, M. , Bryan, J.G. , Humeidi, R. , Peck, D. , Wu, X. , Tang, A.A. , Wang, V.M. , Bender, S.A. , Lemire, E. , Narayan, R. , Montgomery, P. , Ben-David, U. , Garvie, C.W. , Chen, Y. , Rees, M.G. , Lyons, N.J. , McFarland, J.M. , Wong, B.T. , Wang, L. , Dumont, N. , O, P.J. , Stefan, E. , Doench, J.G. , Harrington, C.N. , Greulich, H. , Meyerson, M. , Vazquez, F. , Subramanian, A. , Roth, J.A. , Bittker, J.A. , Boehm, J.S. , Mader, C.C. , Tsherniak, A. , Golub, T.R. : Discovering the anticancer potential of non-oncology drugs by systematic viability profiling. Nature Cancer (jan 2020). https://doi.org/10.1038/s43018-019-0018-6, http://www.nature.com/articles/s43018-019-0018-6 4. Dempster, J.M. , Rossen, J. , Kazachkova, M. , Pan, J. , Kugener, G. , Root, D.E. , Tsherniak, A. : Extracting biological insights from the project achilles genome-scale CRISPR screens in cancer cell lines. BioRxiv (jul 2019). https://doi.org/10.1101/720243, http://biorxiv.org/lookup/doi/10.1101/720243 5. DepMap, B. : DEMETER 2 combined RNAi. Figshare (2019). https://doi.org/10.6084/m9.figshare.9170975.v1, http://figshare.com/articles/{DEMETER_2_Combined_RNAi}/9170975/1
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|